SUMMARY Four assays of rheumatoid factor (RF) have been measured on serum from 213 individuals from 13 families containing at least two sufferers from classical or definite rheumatoid arthritis (RA). Families were not uniformly RF positive or negative, and there was no evidence that non-RA RF positivity was inherited. Four individuals developed definite RA over a two year period, showing that the family members were at increased risk of RA. IgG RF and latex RF assays predicted the RA in the four cases. An association of RF positivity in RA with DR4 was observed, but this may be related to disease severity.
The role of rheumatoid factor (RF) in the aetiopathogenesis of RA remains unclear. It is known that RFs may be present before the onset of clinical disease,' but more usually RFs are not detectable in serum until several months after onset, and some patients with clinical RA remain persistently seronegative by conventional RF tests. Evidence that seropositive and seronegative RA may be different diseases is suggested by a recent report showing that each has different strengths of association with different HLA antigens.2 Different patterns of radiological involvement in seropositive and seronegative RA have also been reported. 3 The observation that seropositive RA is more familial4 might suggest that RF itself is inherited. RF positivity, however, is associated with more severe and more active disease, and the familial nature of RF positivity in RA may be related solely to disease severity. Little is known of the predictive value of RF tests for RA, but in one population based study three individuals developing RA had previously been RF positive compared with one who had been seronegative.5 A predictive role for RF was also found by Aho et The 10 seronegative RA patients by RAHA occurred in seven families, the 10 IgG seronegative RA patients occurred in six families, the 20 SCAT negative RA patients were from 10 families, and the 18 latex negative RA patients were from 11 families. The four RA sufferers negative by all four tests were from four different families. The patients with RF negative RA were therefore spread through several families, and families are not uniformly RF positive or RF negative. Table 2 shows the association of positive RF tests with HLA-DR4. If, however, individuals with classical and definite RA were excluded leaving only the false positives (Table 3) then no association was shown with DR4. HLA-DR4 was therefore associated with rheumatoid disease rather than RF positivity. No association was found with any other DR antigens. Fig. 1 shows the relation of RAHA titre and IgG RF index to the inheritance of HLA-DR4 (homozygous, heterozygous, and non-DR4) in individuals suffering from classical and definite RA. There were two individuals in whom it was unclear whether they were homozygous DR-4, or 4,blank and these have been excluded from this figure. There was no significant difference in the titre of RF positivity between these groups. Neither HLA-DR4 nor homozygosity for HLA-DR4 were associated with higher titre seropositivity, although for IgG RF there is a trend towards more RF the greater the number of DR4 antigens inherited. Table 4 shows the prevalence of RA and positive RF tests in index cases and their relatives. This shows that the prevalence of RA and positive RF tests fell with increasing degree of relativity to the proband, and the >i2 degree relatives have similar prevalence of disease to the non-blood relatives. The association of non-RA (false) positive RF tests and degree of relativity to the proband is shown in Table 5 . The percentage positivity was variable and showed no trend. Table 6 shows the classical and definite RA cases and their seropositivity by degree of relativity to the proband. Distant relatives showed a trend towards less seropositivity, but this was well short of statistical significance and may be accounted for by the decreasing severity of the disease.
These results again imply that RF positivity was not inherited per se, but only as part of RA. Table 7 . Each test has been considered separately in order to assess the predictive value of each. The one individual who declined to be followed up was seropositive by IgG rheumatoid factor alone, and while we did not have follow up samples we knew him to be asymptomatic. Three individuals from this false positive group had developed classical or definite RA. These three cases are summarised in Table 8 . Only one individual from the control group developed symptoms sufficient for a diagnosis of probable RA. These Onset of symptoms had been three months before the first assessment. Details of this individual appear in Table 9 .
Discussion
These results suggest that the assays for RF differ in their specificity and sensitivity. The follow up study of individuals with false positive rheumatoid factor tests showed that rheumatoid factor positivity did not uniformly predict the onset of RA over a two year period. The finding of four individuals who had developed classical or definite RA (three from the false positive group and one from the probable RA group) in a population of 175 over a two year period showed a very high incidence of RA and implies that family members were indeed at increased risk of developing RA. The observation that one of these individuals was not a blood relative illustrates that this increased risk may not be entirely inherited. An estimate of the expected incidence of RA in a population of 175 over two years is approximately 0-2 cases (assuming 2% prevalence being achieved over a 20 year onset period). All cases who developed definite RA were RF positive before the onset of symptoms. The observation that in three of the four new cases of RA the IgG RF index was falling suggests that IgG RF may be involved in the onset of RA. Only IgG rheumatoid factor and the latex assay predicted all new definite RA cases, and no cases of definite RA occurred in the RF negative control group. Nine false positives had on follow up become RF negative, and therefore the risk of RA appeared to be greater in persistently RF positive individuals. The increased risk of developing RA in the false positive group was mainly in DR4 positive individuals.
